FDA Drug Recalls

Recalls / Class II

Class IID-0137-2021

Product

B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Affected lot / code info
Lot #1111202001, Exp 01/11/2021

Why it was recalled

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Recalling firm

Firm
Advanced Nutriceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
836 E 86th St, N/A, Indianapolis, Indiana 46240-1806

Distribution

Quantity
1 vials
Distribution pattern
CA, CO, FL, IN, KY, OH, TX

Timeline

Recall initiated
2020-11-30
FDA classified
2020-12-11
Posted by FDA
2020-12-23
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0137-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls